Cargando…

Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study

Sickle cell disease (SCD) induces a chronic prothrombotic state. Central venous access devices (CVADs) are commonly used for chronic transfusions and iron chelation in this population. CVADs are an additional venous thromboembolism (VTE) risk factor. The role of thromboprophylaxis in this setting is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forté, Stéphanie, De Luna, Gonzalo, Abdulrehman, Jameel, Fadiga, Nafanta, Pestrin, Olivia, Pham Hung d’Alexandry d’Orengiani, Anne-Laure, Aneke, John Chinawaeze, Guillet, Henri, Budhram, Dalton, Habibi, Anoosha, Ward, Richard, Bartolucci, Pablo, Kuo, Kevin H. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910838/ https://www.ncbi.nlm.nih.gov/pubmed/35268283 http://dx.doi.org/10.3390/jcm11051193

Ejemplares similares

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic
por: De Luna, Gonzalo, et al.
Publicado: (2020)

Psychometric characteristics of the Revised Illness Perception Questionnaire (IPQ-R) in adults with sickle cell disease
por: Oudin Doglioni, Damien, et al.
Publicado: (2021)

Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic
por: Pelinski, Yanís, et al.
Publicado: (2021)

Characterisation of different forms of the accessory gp3 canine coronavirus type I protein identified in cats
por: Pham-Hung d’Alexandry d’Orengiani, Anne-Laure, et al.
Publicado: (2015)

Variation and impact of polygenic hematologic traits in monogenic sickle cell disease
por: Pincez, Thomas, et al.
Publicado: (2022)

Acid phosphatase 2 (ACP2) is required for membrane fusion during influenza virus entry
por: Lee, Jihye, et al.
Publicado: (2017)

Venous Thromboprophylaxis in Spine Surgery
por: Alvarado, Anthony M., et al.
Publicado: (2019)

Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis
por: Minet, Clémence, et al.
Publicado: (2015)

Thromboprophylaxis for venous thromboembolism prevention in hip fracture patients
Publicado: (2017)

ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism
por: Porres-Aguilar, Mateo
Publicado: (2023)

Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
por: Willems, R. A. L., et al.
Publicado: (2023)

Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery?,
por: Akpinar, Evrim Eylem, et al.
Publicado: (2013)

Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis
por: Huang, Jimmy, et al.
Publicado: (2022)

Sickle Cell Disease and Venous Thromboembolism
por: Rahimi, Zohreh, et al.
Publicado: (2011)

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
por: Aryal, Madan Raj, et al.
Publicado: (2020)

Contribution of fetal microchimeric cells to maternal wound healing in sickle cell ulcers
por: Alkobtawi, Mansour, et al.
Publicado: (2022)

The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery
por: Gao, Yuan, et al.
Publicado: (2016)

Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis
por: Ageno, Walter, et al.
Publicado: (2018)

Awareness of venous thromboembolism and thromboprophylaxis among hospitalized patients: a cross-sectional study
por: Almodaimegh, Hind, et al.
Publicado: (2017)

Analysis of Adherence to Thromboprophylaxis and Incidence of Venous Thromboembolism After Lower Limb Orthopaedic Surgery
por: Benjamin, Miles W, et al.
Publicado: (2021)

Venous Thromboembolism Among Hospitalized Patients: Incidence and Adequacy of Thromboprophylaxis – A Retrospective Study
por: Ambra, Naseem, et al.
Publicado: (2022)

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
por: Ko, Meehyun, et al.
Publicado: (2021)

Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysis
por: Lopinto, Julien, et al.
Publicado: (2022)

PB2505: THERAPEUTIC PHLEBOTOMY INSTANTLY AFFECTS BLOOD PARAMETERS AND VISCOCITY IN SICKLE CELL DISEASE PATIENTS
por: Jebali, Amna, et al.
Publicado: (2023)

Screening for Cognitive Dysfunction Using the Rowland Universal Dementia Assessment Scale in Adults With Sickle Cell Disease
por: Forté, Stéphanie, et al.
Publicado: (2021)

Highlights: burden of venous thromboembolism and role of extended-duration thromboprophylaxis in acute medically ill patients
Publicado: (2018)

Venous Thromboembolism Risk and Thromboprophylaxis Assessment in Surgical Patients Based on Caprini Risk Assessment Model
por: Tadesse, Tamrat Assefa, et al.
Publicado: (2020)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Thromboprophylaxis and mortality among patients who developed venous thromboembolism in seven major hospitals in Saudi Arabia
por: Al-Hameed, Fahad M., et al.
Publicado: (2017)

The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
por: Zhang, Chuanlin, et al.
Publicado: (2019)

Approach to Thromboprophylaxis for Prevention of Venous Thromboembolism in COVID-19: Global Updates and Clinical Insights from India
por: Ramakrishnan, Nagarajan, et al.
Publicado: (2022)

Post-hepatectomy venous thromboembolism: a systematic review with meta-analysis exploring the role of pharmacological thromboprophylaxis
por: Karunakaran, Monish, et al.
Publicado: (2022)

Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study
por: Kemp, Megan, et al.
Publicado: (2023)

Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence
por: Cunningham, M S, et al.
Publicado: (2006)

Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study
por: Vallano, Antonio, et al.
Publicado: (2004)

Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
por: Thein, Swee Lay, et al.
Publicado: (2020)

Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta‐Analysis
por: Ho, Kwok M., et al.
Publicado: (2015)

High level of venous thromboembolism in critically ill trauma patients despite early and well-driven thromboprophylaxis protocol
por: Hamada, S. R., et al.
Publicado: (2017)

Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis
por: Chi, Gerald, et al.
Publicado: (2020)

COVID-19 and venous thromboembolism risk in patients with sickle cell disease
por: Singh, Ashima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ovet2u48leoo339v0t30eg5hnd